Does Dr. ARDALAN AMINLARI have financial conflicts of interest?

Dr. ARDALAN AMINLARI (MD) has received a total of $25,938 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $12,348 in personal promotional payouts (consulting, meals, travel) and $13,590 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ARDALAN AMINLARI?

According to CMS Open Payments data, Dr. ARDALAN AMINLARI received funding from SIGHT SCIENCES ($13,609), GLAUKOS CORPORATION ($6,729), and ALCON VISION ($2,844).

Does Dr. ARDALAN AMINLARI receive research grants or speaking fees?

Dr. ARDALAN AMINLARI has received $12,348 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $13,590 in clinical research grants.

DR. ARDALAN AMINLARI

MDReal-Time Hydrated

Specialty: Ophthalmology, Glaucoma Specialist

Practice Location: ENCINITAS, CA 92024

NPI Number: 1639497258

LIFETIME INDUSTRY VALUE

$25,938

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. AMINLARI is a verified Ophthalmology, Glaucoma Specialist practitioner based in ENCINITAS, CA.

Between 2021 and 2024, Dr. AMINLARI had an overall industry promotional and research financial footprint of $25,938 as recorded in the federal CMS Open Payments database.

$12,348 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$13,590 was allocated to sponsored clinical trials and medical research activities.

Dr. AMINLARI's primary funding source is SIGHT SCIENCES, which accounts for $13,609 (representing 52.5% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

SIGHT SCIENCES

Rank 1

$13,609

52.5%

GLAUKOS CORPORATION

Rank 2

$6,729

25.9%

ALCON VISION

Rank 3

$2,844

11%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.